Codice QR

Letrozole and palbociclib in advanced breast cancer: Outcome from cancer institute, Chennai

Background: Cyclin-dependent kinase 4/6 inhibitor addition to hormonal therapy has shown to improve the survival of hormone receptor (HR)-positive, HER2-negative advanced breast cancer (ABC). Methods: We retrospectively analyzed untreated patients with HR-positive, HER2-negative ABC, who received le...

Descrizione completa

Salvato in:
Autori principali: Vijay Gnanaguru, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Jayachandran Perumal Kalaiarasi, Nikita Mehra, Archit Joshi, Arun Kumar Rajan, Gangothri Selvarajan, Parathan Karunakaran, Balasubramanian Ananthi, Priya Iyer, Geetha Senguttuvan, Manjula Rao, Madhu Priya, Arvind Krishnamurthy, Sridevi Velusamy, Hemanth Raj, Rama Ranganathan, Shirley Sundersingh, Krishna Kumar, Selvaluxmy Ganesarajah, Trivadi S Ganesan, Tenali Gnana Sagar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Serie:Indian Journal of Medical and Paediatric Oncology
Soggetti:
advanced breast cancer
letrozole
palbociclib
Accesso online:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=2;spage=182;epage=186;aulast=
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi